Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center Unblinded Proof-of-Concept Study of DaxibotulinumtoxinA for Migraine: the 'EEG Paradigm'

NCT06154070 is registered in ClinicalTrials.gov with Ki Health Partners. LLC as lead sponsor.

NCT NCT06154070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06154070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center Unblinded Proof-of-Concept Study of DaxibotulinumtoxinA for Migraine: the 'EEG Paradigm'
Lead sponsor
Ki Health Partners. LLC
Phase
Observational
Overall status
Unknown status
Start date
October 24, 2023
Completion date
October 31, 2024
Enrollment
10 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

migraine disorders